Status:

COMPLETED

Assessment of Duration of Erection With Vardenafil 10 mg

Lead Sponsor:

Bayer

Collaborating Sponsors:

GlaxoSmithKline

Conditions:

Erectile Dysfunction

Eligibility:

MALE

18-64 years

Phase:

PHASE4

Brief Summary

This study assessed the effect of 10mg vardenafil, taken on demand in an 'at home' setting, as compared to placebo (dummy medication with no pharmacological activity), on the duration of erection from...

Eligibility Criteria

Inclusion

  • Males with erectile dysfunction- Stable heterosexual relationship

Exclusion

  • Primary hypoactive sexual desire- History of myocardial infarction, stroke or life-threatening arrhythmia within the prior 6 months nitrate use

Key Trial Info

Start Date :

September 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2005

Estimated Enrollment :

201 Patients enrolled

Trial Details

Trial ID

NCT00663728

Start Date

September 1 2004

End Date

April 1 2005

Last Update

December 30 2014

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Assessment of Duration of Erection With Vardenafil 10 mg | DecenTrialz